Transition of Patients with Opioid Use Disorder from Buprenorphine to Extended‐Release Naltrexone: A Randomized Clinical Trial Assessing Two Transition Regimens

por Comer, Sandra D., Mannelli, Paolo, Alam, Danesh, Douaihy, Antoine, Nangia, Narinder, Akerman, Sarah C., Zavod, Abigail, Silverman, Bernard L., Sullivan, Maria A.
Publicado 2020

Opioid system modulation with buprenorphine/samidorphan combination for major depressive disorder: two randomized controlled studies

por Fava, Maurizio, Thase, Michael E., Trivedi, Madhukar H., Ehrich, Elliot, Martin, William F., Memisoglu, Asli, Nangia, Narinder, Stanford, Arielle D., Yu, Miao, Pathak, Sanjeev
Publicado 2018

Narsoplimab, a Mannan-Binding Lectin-Associated Serine Protease-2 Inhibitor, for the Treatment of Adult Hematopoietic Stem-Cell Transplantation–Associated Thrombotic Microangiopath...

por Khaled, Samer K., Claes, Kathleen, Goh, Yeow Tee, Kwong, Yok Lam, Leung, Nelson, Mendrek, Włodzimierz, Nakamura, Ryotaro, Sathar, Jameela, Ng, Edmund, Nangia, Narinder, Whitaker, Steve, Rambaldi, Alessandro
Publicado 2022

Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study

por Naismith, Robert T, Wolinsky, Jerry S, Wundes, Annette, LaGanke, Christopher, Arnold, Douglas L, Obradovic, Dragana, Freedman, Mark S, Gudesblatt, Mark, Ziemssen, Tjalf, Kandinov, Boris, Bidollari, Ilda, Lopez-Bresnahan, Maria, Nangia, Narinder, Rezendes, David, Yang, Lili, Chen, Hailu, Liu, Shifang, Hanna, Jerome, Miller, Catherine, Leigh-Pemberton, Richard
Publicado 2019